1522P Camrelizumab plus chemotherapy versus concurrent chemoradiotherapy as neoadjuvant therapy for resectable thoracic oesophageal squamous cell cancer (REVO): A multicenter, randomized, open-label, phase II trial

作者：W.P. Yuan, YangQuan Chen, Jia Liu, Weihe Zhang, Xiaodan Chen, Hao He, Peng Chen, J-P. Lin, Dou Zhang, Hui Lin, Wenjin Wei, Wen Chen, Hang Zhou, Ping Gao, Shiyin Liu, Fang Wang · 发表于：Annals of Oncology · 年份：2023 · DOI：10.1016/j.annonc.2023.09.1435 · 被引用次数：5 · 研究领域：Esophageal Cancer Research and Treatment、Cancer Immunotherapy and Biomarkers、Gastric Cancer Management and Outcomes